Hirasawa Noriyasu, Ohsawa Yuhsuke, Katoh Goh, Shibata Kazue, Ishihara Kenji, Seyama Toshio, Tamura Soichiro, Hong JangJa, Ohuchi Kazuo
Laboratory of Pathophysiological Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
Int Arch Allergy Immunol. 2009;148(4):279-88. doi: 10.1159/000170381. Epub 2008 Nov 11.
In atopic dermatitis, inflammation induced by antigen-nonspecific stimuli further enhances the allergic inflammation. However, there is no experimental model in which allergic dermatitis is evoked where the inflammation has been induced by antigen-nonspecific stimuli. Here, we established a novel dermatitis model in mice and analyzed the role of histamine.
After sensitization with picryl chloride (PiCl) by painting on ear lobes of cyclophosphamide-treated mice, 12-O-tetradecanoylphorbol 13-acetate (TPA) was painted twice at the same site, and then allergic inflammation was induced by painting PiCl. Histamine antagonists and cyclosporine A (CsA) were administered intravenously.
The application of TPA shifted the PiCl-induced allergic inflammation from a delayed-type response to a biphasic response, increased the infiltration of eosinophils and mast cells at the inflammatory site, shifted the cytokine milieu from Th1 to Th2 and induced the expression of thymic stromal lymphopoietin in the ear lobes. The PiCl-induced increase in the thickness of the ear lobe in the immediate phase was suppressed by the H1 antagonist pyrilamine. In contrast, the increase in the swelling in the late phase and the infiltration of eosinophils were suppressed by the H3/H4 antagonist thioperamide. The inhibitory effect of the combined treatment with pyrilamine and thioperamide on the TPA-modified contact dermatitis was as potent as that of CsA.
Induction of the antigen-nonspecific inflammation by TPA enhanced the PiCl-induced allergic inflammation. Histamine plays significant roles in the early-phase swelling via H1 receptors, and the late-phase swelling via H3/H4 receptors in this TPA-modified allergic dermatitis model.
在特应性皮炎中,抗原非特异性刺激诱导的炎症会进一步加剧过敏性炎症。然而,尚无通过抗原非特异性刺激诱导炎症后引发过敏性皮炎的实验模型。在此,我们建立了一种新型小鼠皮炎模型,并分析了组胺的作用。
在用环磷酰胺处理的小鼠耳垂上涂抹苦味酸(PiCl)致敏后,在同一部位涂抹两次12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA),然后通过涂抹PiCl诱导过敏性炎症。静脉注射组胺拮抗剂和环孢素A(CsA)。
TPA的应用将PiCl诱导的过敏性炎症从迟发型反应转变为双相反应,增加了炎症部位嗜酸性粒细胞和肥大细胞的浸润,使细胞因子环境从Th1型转变为Th2型,并诱导耳垂中胸腺基质淋巴细胞生成素的表达。H1拮抗剂吡苄明抑制了PiCl诱导的耳垂即时相厚度增加。相反,H3/H4拮抗剂硫代哌啶抑制了迟发型肿胀和嗜酸性粒细胞浸润。吡苄明和硫代哌啶联合治疗对TPA诱导的接触性皮炎的抑制作用与CsA相当。
TPA诱导的抗原非特异性炎症增强了PiCl诱导的过敏性炎症。在这个TPA诱导的过敏性皮炎模型中,组胺通过H1受体在早期肿胀中起重要作用,通过H3/H4受体在晚期肿胀中起重要作用。